NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

Nick McDonald

1 min read

AGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site

August 9, 2021 at 10:00 PM
Press Release
Read press release

1 min read

AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings

August 5, 2021 at 9:00 AM
Press Release
Read press release

1 min read

AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site

August 2, 2021 at 11:00 AM
Press Release
Read press release

2 min read

AGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings

July 1, 2021 at 9:00 AM
Press Release
Read press release

4 min read

Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III

June 23, 2021 at 5:30 AM
Press Release
Read press release

1 min read

AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine

June 7, 2021 at 7:00 AM
Press Release
Read press release

2 min read

AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics

May 19, 2021 at 10:06 AM
Press Release
Read press release

2 min read

Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02

May 6, 2021 at 7:00 AM
Events and Conferences
Read press release

1 min read

Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility

April 30, 2021 at 7:00 AM
Read press release

1 min read

AGC Biologics Expands Partnership with Rocket Pharmaceuticals

April 20, 2021 at 6:53 AM
Press Release
Read press release
Prev 4 5 6 7 8 Next